Nps Pharmaceuticals' Unattributed VC Round

Nps Pharmaceuticals raised a round of funding on February 07, 2000.

NPS Pharmaceuticals is developing specialty therapeutics for gastrointestinal and endocrine disorders. The company is currently advancing two late-stage programs: GATTEX (teduglutide) is in Phase 3 cl…

Articles about Nps Pharmaceuticals' Unattributed VC Round: